CASE REPORT
Year : 2014  |  Volume : 5  |  Issue : 1  |  Page : 182-183

Dexmedetomidine induced catecholamine suppression in pheochromocytoma


1 Department of Anaesthesia and Intensive care, School of Medical Sciences, College of Health Sciences, Fellow Department of Cardiac Anaesthesia, NHIMS, Bangalore, Karnataka, India.
2 Department of Anaesthesia and Intensive care, University Health Services, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, West Africa

Correspondence Address:
Sanjeev Singh
Department of Cardiac Anaesthesia, NHIMS, Bangalore, Karnataka, India.

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-9668.127323

Rights and Permissions

Pheochromocytoma is a neuroendocrine tumour of chromaffin cells, though rare but a known cause of paroxysmal hypertension with a triad of headache, diaphoresis and palpitation. The biochemical diagnosis of pheochromocytoma is based on estimation of plasma nor-adrenaline, adrenaline and their metabolites in plasma or urine. Clonidine suppression test is performed to differentiate the raised catecholamine level due to pheochromocytoma or other than heochromocytoma especially in cases where plasma nor-adrenaline levels are less than 2000 pg/ml. Clonidine is stated to be unable to suppress catecholamine level in cases of pheochromocytoma, therefore we tested the other α2-agonist Dexmedetomidine intravenous in a case of Pheochromocytoma with remarkably raised nor- adrenaline (25,183 pg/ml) and found 49.42% suppression.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2211    
    Printed61    
    Emailed0    
    PDF Downloaded432    
    Comments [Add]    
    Cited by others 4    

Recommend this journal